Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 1;161(8):879-881.
doi: 10.1001/jamadermatol.2025.1520.

Auditory and Ocular Manifestations in Pediatric Vitiligo

Affiliations

Auditory and Ocular Manifestations in Pediatric Vitiligo

Serena Yun-Chen Tsai et al. JAMA Dermatol. .
No abstract available

Plain language summary

This cohort study analyzed the association of pediatric vitiligo with auditory and ocular manifestations.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Harris reported receiving grants from the Pediatric Dermatology Research Alliance and Core studies: Incyte, Barinthus Bio NA, NexImmune, and Cour Pharma during the conduct of the study; personal fees from Alys Pharmaceuticals, Incyte, Matchpoint Therapeutics, Vividion, AbbVie, Aclaris, Almirall, Bain Capital, and Avoro outside the submitted work; consulting fees from Alys Pharmaceuticals, Incyte, Avoro, Matchpoint Therapeutics, Vividion, AbbVie, Aclaris, Almirall, and Bain Capital; is a founder of and owns stock in Incyte and Alys Pharmaceuticals; and serves as Chief Innovation Officer for Alys Pharmaceuticals. Dr Garza-Mayers reported serving on a dupilumab advisory board for Sanofi not relevant to this work, and salary support from a Weston Career Development Award from the Society for Pediatric Dermatology and the Pediatric Dermatology Research Alliance. No other disclosures were reported.

References

    1. Li CL, Ma SH, Wu CY, Chang PH, Chang YT, Wu CY. Association between sensorineural hearing loss and vitiligo: a nationwide population-based cohort study. J Eur Acad Dermatol Venereol. 2022;36(7):1097-1103. doi: 10.1111/jdv.18047 - DOI - PubMed
    1. LeWitt T, Tauscher R, Obiofuma G, Peterson J, Haddadin R, Kundu RV. Ocular manifestations of vitiligo: a systematic review. BMC Ophthalmol. 2023;23(1):120. doi: 10.1186/s12886-023-02777-9 - DOI - PMC - PubMed
    1. Price ER, Fisher DE. Sensorineural deafness and pigmentation genes: melanocytes and the Mitf transcriptional network. Neuron. 2001;30(1):15-18. doi: 10.1016/S0896-6273(01)00259-8 - DOI - PubMed
    1. Aslan S, Serarslan G, Teksoz E, Dagli S. Audiological and transient evoked otoacoustic emission findings in patients with vitiligo. Otolaryngol Head Neck Surg. 2010;142(3):409-414. doi: 10.1016/j.otohns.2009.11.007 - DOI - PubMed
    1. Genedy R, Assal S, Gomaa A, Almakkawy B, Elariny A. Ocular and auditory abnormalities in patients with vitiligo: a case-control study. Clin Exp Dermatol. 2021;46(6):1058-1066. doi: 10.1111/ced.14649 - DOI - PubMed

LinkOut - more resources